[ad_1]
| All news about NATCO PHARMA LIMITED |
|
|
|
|
|
|
|
| Sale 2023 |
29 037 M
359 M
359 M
|
| Net income 2023 |
8 527 M
105 M
105 M
|
| Net debt 2023 |
–
–
–
|
| P/E ratio 2023 |
12.5x |
| Harvest 2023 |
1.27% |
|
| Capitalization |
106 B
1 309 M
1 309 M
|
| Cap. / Sale 2023 |
3.65x |
| Cap. / Sale 2024 |
2.96x |
| Number of employees |
4 025 |
| Free-Float |
48.6% |
|
| Chart NATCO PHARMA LIMITED |
|
Duration:
Period:
|
 |
|
|
Technical Analysis Trends NATCO PHARMA LIMITED
|
Short term |
Medium term |
A long time |
| Trends |
Bearish |
Bearish |
Bearish |
Evolution of the Income Statement
|
|
| Average consensus |
PRIVILEGE |
| Number of analysts |
12 |
| Final closing price |
580.45 INR |
| Average target price |
715.33 INR |
| Spread / Average Target |
23.2% |
|
[ad_2]
Source link
